Daniel Ratschiller
Overview
Explore the profile of Daniel Ratschiller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fos J, Pabst T, Petkovic V, Ratschiller D, Mueller B
Blood
. 2011 Mar;
117(18):4881-4.
PMID: 21389317
CCAAT/enhancer binding protein-α (CEBPA) mutations in acute myeloid leukemia (AML) patients with a normal karyotype (NK) confer favorable prognosis, whereas NK-AML patients per se are of intermediate risk. This suggests...
2.
Rothschild S, Kappeler A, Ratschiller D, Betticher D, Tschan M, Gugger M, et al.
Lung Cancer
. 2010 Aug;
71(3):306-11.
PMID: 20709421
Aims: Inhibitor of differentiation 1 (ID1) plays a role in cellular differentiation, proliferation, angiogenesis and tumor invasion. As shown recently, ID1 is positively regulated by the tyrosine kinase SRC in...
3.
Gautschi O, Ratschiller D, Gugger M, Betticher D, Heighway J
Lung Cancer
. 2006 Oct;
55(1):1-14.
PMID: 17070615
Purpose: To review the evidence implicating the deregulation of cyclin D1 in the pathogenesis of non-small cell lung cancer (NSCLC), and to discuss the opportunities for targeted clinical intervention. Methods:...
4.
Gautschi O, Hugli B, Ziegler A, Bigosch C, Bowers N, Ratschiller D, et al.
Lung Cancer
. 2006 Jan;
51(3):303-11.
PMID: 16406195
Purpose: The cyclin D1 (CCND1) A870G gene polymorphism is linked to the outcome in patients with resectable non-small cell lung cancer (NSCLC). Here, we investigated the impact of this polymorphism...
5.
Bienz M, Ludwig M, Oppliger Leibundgut E, Mueller B, Ratschiller D, Solenthaler M, et al.
Clin Cancer Res
. 2005 Mar;
11(4):1416-24.
PMID: 15746041
Purpose: The recognition of a number of leukemia-specific cytogenetic abnormalities and their role as independent prognostic factors have provided considerable insights into leukemia pathogenesis and have paved the way to...
6.
Gautschi O, Bigosch C, Huegli B, Jermann M, Marx A, Chasse E, et al.
J Clin Oncol
. 2004 Oct;
22(20):4157-64.
PMID: 15483026
Purpose: Circulating cell-free DNA is present in increased amounts in the blood of cancer patients, but the clinical relevance of this phenomenon remains unclear. We conducted a clinical study to...
7.
Smith S, Watson S, Ratschiller D, Gugger M, Betticher D, Heighway J
Oncogene
. 2003 Dec;
22(54):8677-87.
PMID: 14647462
Maspin, SCCA1/2 and hurpin were identified by cDNA microarray analyses as dramatically differentially expressed transcripts in primary non-small cell lung cancer (NSCLC). These sequences are located within a 10-gene serpin...
8.
Heighway J, Knapp T, Boyce L, Brennand S, Field J, Betticher D, et al.
Oncogene
. 2002 Oct;
21(50):7749-63.
PMID: 12400018
Using a panel of cDNA microarrays comprising 47 650 transcript elements, we have carried out a dual-channel analysis of gene expression in 39 resected primary human non-small cell lung tumours...
9.
Novak U, Oppliger Leibundgut E, Hager J, Muhlematter D, Jotterand M, Besse C, et al.
Blood
. 2002 Aug;
100(5):1787-94.
PMID: 12176901
The most frequent chromosomal aberrations in B-cell chronic lymphocytic leukemia (B-CLL) are deletions on 13q, 11q, and 17p, and trisomy 12, all of which are of prognostic significance. Conventional cytogenetic...